0
 

Ulcerative's Colitis Market - Company Profile (Johnson & Johnson, GlaxoSmithKline plc, Eli Lilly and Co., Sanofi Aventis A/S, AstraZeneca plc, Merck & Co., Inc., InDex Pharmaceuticals Holding AB, Ajinomoto Pharmaceuticals Co., Ltd., and Abbott Laboratories.)and Competitive intelligence report 2017

  • ID: CP_LI_188482
  • September 2017
  • 48 pages
  • Price: $ 595
 
 

The key players of the global ulcerative colitis market are Johnson & Johnson, GlaxoSmithKline plc, Eli Lilly and Co., Sanofi Aventis A/S, AstraZeneca plc, Merck & Co., Inc., InDex Pharmaceuticals Holding AB, Ajinomoto Pharmaceuticals Co., Ltd., and Abbott Laboratories.

 

TOC

Chapter: 1 COMPANY PROFILES

1.1. PFIZER INC.

1.1.1. Company overview

1.1.2. Company snapshot

1.1.3. Operating business segments

1.1.4. Business performance

1.1.5. Key strategic moves and developments

1.2. JOHNSON & JOHNSON

1.2.1. Company overview

1.2.2. Company snapshot

1.2.3. Operating business segments

1.2.4. Business performance

1.2.5. Key strategic moves and developments

1.3. GLAXOSMITHKLINE PLC

1.3.1. Company overview

1.3.2. Company snapshot

1.3.3. Operating business segments

1.3.4. Business performance

1.3.5. Key strategic moves and developments

1.4. ELI LILLY AND CO.

1.4.1. Company overview

1.4.2. Company snapshot

1.4.3. Operating business segments

1.4.4. Business performance

1.4.5. Key strategic moves and developments

1.5. SANOFI AVENTIS A/S

1.5.1. Company overview

1.5.2. Company snapshot

1.5.3. Operating business segments

1.5.4. Business performance

1.5.5. Key strategic moves and developments

1.6. ASTRAZENECA PLC

1.6.1. Company overview

1.6.2. Company snapshot

1.6.3. Operating business segments

1.6.4. Business performance

1.6.5. Key strategic moves and developments

1.7. MERCK & CO. INC.

1.7.1. Company overview

1.7.2. Company snapshot

1.7.3. Operating business segments

1.7.4. Business performance

1.7.5. Key strategic moves and developments

1.8. ABBOTT LABORATORIES

1.8.1. Company overview

1.8.2. Company snapshot

1.8.3. Operating business segments

1.8.4. Business performance

1.8.5. Key strategic moves and developments

1.9. INDEX PHARMACEUTICALS HOLDING AB

1.9.1. Company overview

1.9.2. Company snapshot

1.9.3. Operating business segments

1.9.4. Key strategic moves and developments

1.10. AJINOMOTO PHARMACEUTICALS CO., LTD.

1.10.1. Company overview

1.10.2. Company snapshot

1.10.3. Operating business segments

1.10.4. Key strategic moves and developments

 

LIST OF TABLES AND FIGURES

TABLE 1. PFIZER: COMPANY SNAPSHOT

TABLE 2. PFIZER: OPERATING SEGMENTS

TABLE 3. J&J: COMPANY SNAPSHOT

TABLE 4. J&J: OPERATING SEGMENTS

TABLE 5. GSK: COMPANY SNAPSHOT

TABLE 6. GSK: OPERATING SEGMENTS

TABLE 7. ELI: COMPANY SNAPSHOT

TABLE 8. ELI: OPERATING SEGMENTS

TABLE 9. SANOFI: COMPANY SNAPSHOT

TABLE 10. SANOFI: OPERATING SEGMENTS

TABLE 11. ASTRAZENECA: COMPANY SNAPSHOT

TABLE 12. ASTRAZENECA: OPERATING SEGMENTS

TABLE 13. MERCK: COMPANY SNAPSHOT

TABLE 14. MERCK: OPERATING SEGMENTS

TABLE 15. ABBOTT: COMPANY SNAPSHOT

TABLE 16. ABBOTT: OPERATING SEGMENTS

TABLE 17. INDEX: COMPANY SNAPSHOT

TABLE 18. INDEX: OPERATING SEGMENTS

TABLE 19. AJINOMOTO: COMPANY SNAPSHOT

TABLE 20. AJINOMOTO: OPERATING SEGMENTS

Purchase Options

 

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers